Jack Hunter, editor of Rare Politics. and Jarad Geldner, senior adviser for the Democratic Coalition, discuss Washington's busy week. They cover everything from what could be a government shutdown on Friday, to the RNC's endorsement of Roy Moore, to the Senate's recent passing of tax reform.
We dig into the rescheduling of Senate Minority Leader Chuck Schumer and House Minority Leader Nancy Pelosi's meeting with the President. The two top democrats will argue for a fix for both CHIP and DACA in the budget. Jarad discusses the overall feeling in Washington as tense ahead of Friday's spending deadline.
Jack weighs in on the RNC's recent embrace of Roy Moore, alleged child sex offender and Alabama candidate for Senate. Hunter notes that the alleged behavior is deplorable, and no one should be dismissing it. Jack also discusses why some Senate Republicans, like John McCain, suddenly jumped on board tax reform. He points out that the number one concern of the Republican party has always been taxes, which is why they were able to pass it as easily as they did.
Manhattan District Attorney Alvin Bragg filed a federal lawsuit against Rep. Jim Jordan on Tuesday, accusing the Republican of a “transparent campaign to intimidate and attack” him over his prosecution of former President Donald Trump.
Nashville’s governing council voted Monday to send Justin Jones straight back to the Legislature four days after he was expelled for his role in a protest on the state House floor.
The Justice Department is calling a Texas court ruling that would halt approval of the most commonly used method of abortion in the U.S. "extraordinary and unprecedented."
Nashville city councilors will likely appoint Justin Jones to his former seat on Monday while Memphis-area county commissioners will soon announce when they'll meet to fill the vacancy left by the expulsion of Justin Pearson, which Pearson himself is eligible to fill.
Health and Human Services Secretary Xavier Becerra said "Everything is on the table" when asked if he'd recommend that the FDA ignore Friday's ruling to reverse the agency's nearly 23-year-old approval of the medication abortion drug mifepristone.
